Prosecutors allege seven transactions involving real estate, luxury vehicles, and a private aircraft converted proceeds from a $268 million skin-substitute reimbursement scheme into valuable property, although every accusation remains unproven and subject to adversarial testing.
WASHINGTON, DC — Federal prosecutors accuse Michael McMillan of spending millions of dollars allegedly derived from fraudulent Medicare, TRICARE, and CHAMPVA wound-care reimbursements on residences, luxury vehicles, and a private aircraft while operating Protectus LLC and several related companies.
The nine-count indictment does not charge a separate conspiracy to conceal money through an elaborate international network, but it alleges seven domestic monetary transactions involving criminally derived property worth more than $10,000, the threshold governing the charged federal offense.
Those seven counts identify approximately $6.28 million in transfers connected to four real-estate purchases, a Lamborghini, a Cadillac Escalade, and a Cessna Citation aircraft, creating a transaction-by-transaction financial case alongside the broader healthcare-fraud and kickback conspiracies.
McMillan has not been convicted; the properties and payments described by prosecutors have not been proven to contain illegal proceeds, and the United States must establish every element of every count beyond a reasonable doubt through admissible evidence.
Seven Transactions Form the Financial Core
According to the federal indictment against Michael McMillan, Counts Three through Nine allege that he knowingly engaged or attempted to engage in seven transactions involving property derived from two specified unlawful activities charged elsewhere in the same case.
The government identifies conspiracy to commit healthcare fraud and conspiracy to defraud the United States while paying federal healthcare kickbacks as the alleged predicate crimes that generated the money later used for the listed purchases.
Prosecutors must therefore build a financial bridge from allegedly unlawful skin-substitute claims, through medical-provider reimbursements and Protectus collections, to the specific accounts and payments tied to each residence, vehicle, or aircraft named in the transaction table.
The indictment supplies approximate dates, originating accounts, property descriptions, and transfer amounts, but it does not publicly present the complete bank records, closing files, loan documents, accounting ledgers, or tracing analysis upon which the government may rely.
That missing detail will emerge through discovery and litigation, where the defense can test whether each listed amount came from allegedly criminal receipts, legitimate business revenue, financing, investment proceeds, personal funds, or a combination of several sources.
Transactional Money Laundering Requires No Secret Maze
The charged offense, commonly described as transactional money laundering, focuses upon knowingly conducting a qualifying monetary transaction exceeding $10,000 with property derived from specified unlawful activity, rather than requiring prosecutors to prove an elaborate effort to disguise ownership.
This distinction matters because popular descriptions of money laundering often emphasize shell companies, offshore accounts, nominees, layered transfers, or falsified invoices, while the federal statute charged here can reach a comparatively straightforward purchase involving knowingly tainted funds.
The government does not need to prove that every dollar in a mixed account was criminal, but it must present a legally sufficient tracing theory connecting the identified transaction with proceeds from the underlying conspiracies alleged against McMillan.
McMillan’s lawyers can challenge both knowledge and source, arguing that ordinary purchases made openly through established accounts do not demonstrate awareness that the money was criminally derived, particularly when operating companies also generated potentially lawful commercial revenue.
The statute also does not permit conviction merely because an expensive asset was purchased after disputed healthcare payments arrived, since timing, wealth, or extravagance cannot replace proof that qualifying unlawful proceeds actually funded the charged transaction.
The Alleged $268 Million Reimbursement Stream
Prosecutors say McMillan controlled Protectus LLC, Protectus Technologies LLC, Protectus Consulting LLC, Prestige Medical Consultants LLC, Velare Wound Care LLC, and Amnio ReGen Solutions LLC during an alleged operation extending from May 2019 through at least February 2026.
Through those companies, McMillan allegedly supplied skin-substitute products to physicians, podiatrists, nurse practitioners, and other providers without requiring upfront payment, while Protectus employees either prepared government claims or helped participating practices complete their billing.
If Medicare, TRICARE, or CHAMPVA denied reimbursement, the provider allegedly owed nothing for the associated product, but a successful claim triggered an invoice calculated as approximately 60 percent to 70 percent of the government payment.
That structure allegedly allowed providers to retain approximately 30 percent to 40 percent of every paid claim, an economic benefit prosecutors characterize as an illegal kickback disguised through commercial language describing rebates, discounts, or provider profits.
The indictment says government programs paid approximately $268 million on claims connected to the operation, providers retained roughly $94 million, and Protectus companies received approximately $174 million before accounting for other expenses, commissions, purchases, taxes, or transfers.
McMillan and Protectus also allegedly paid approximately $27 million to sales representatives whose compensation depended upon reimbursements generated by recruited providers, creating another payment layer that authorities contend rewarded federally reimbursable referrals and purchasing decisions.
Those aggregate figures explain the alleged source pool, but they do not automatically establish that the seven charged purchases contained criminal proceeds, because each financial count requires evidence connecting a particular transaction with the alleged predicates.
Count Three Identifies a Dallas Condominium Payment
Count Three concerns an approximately $1,010,166 payment dated December 1, 2021, originating from an account in McMillan’s name and associated with a condominium at 2200 Victory Avenue, Unit 2204, in downtown Dallas, Texas.
As the earliest transaction, the Dallas payment allegedly occurred more than two years after the charged conspiracies began, giving investigators a substantial period to examine Protectus claims, provider collections, corporate receipts, and account movements.
Prosecutors may use bank statements, wire records, closing disclosures, title documents, tax records, and internal accounting to show how money reached McMillan’s originating account before the payment connected with the condominium allegedly occurred.
The defense may investigate whether the account held salary, distributions, savings, investment proceeds, loan funds, or revenue predating the alleged scheme, while challenging any tracing method that assumes every incoming Protectus-related transfer had the same character.
The condominium also appears in the forfeiture notice, meaning the government seeks the property or its value if it obtains the required convictions and tracing findings, although indictment language alone does not transfer permanent ownership.
Count Four Focuses on a Lamborghini Payment
Count Four identifies a $60,000 transaction dated July 19, 2023, originating from a Protectus LLC account and connected to the purchase of a 2023 Lamborghini Urus Performance, a vehicle whose luxury branding makes the allegation especially vivid.
The amount listed may represent a deposit, partial payment, or other purchase-related transfer rather than the automobile’s entire price, because the indictment labels each figure as an approximate transaction amount without publishing the complete sales agreement.
For prosecutors, using a Protectus account may simplify the narrative linking company receipts to personal luxury property, but the corporate-account origin does not itself prove the transferred funds came from fraudulent rather than legitimate product sales.
McMillan may contend that the vehicle served a lawful business or personal purpose and was purchased from unrestricted company funds, although the ultimate relevance of purpose remains distinct from whether prosecutors can establish the money’s alleged criminal source.
Jurors would therefore need to evaluate accounting classifications, ownership records, personal-use evidence, tax treatment, repayment arrangements, and the complete flow of funds rather than treating the Lamborghini’s prestige as a substitute for statutory proof.
Count Five Names a Las Vegas Residence
Count Five concerns an approximately $260,466 payment dated September 1, 2023, originating from the same Protectus LLC account identified in the Lamborghini count and associated with property at 9 Oakmont Hills Lane in Las Vegas.
Because two charged transactions allegedly left the same account within roughly six weeks, investigators can compare opening balances, incoming provider payments, intercompany transfers, payroll obligations, product costs, and outgoing expenditures surrounding both dates.
That comparison could strengthen the government’s tracing theory if allegedly tainted receipts closely preceded the transfers, but the defense can argue that an account with substantial lawful revenue requires a more careful, legally supported allocation.
The Las Vegas residence is separately listed among properties sought through forfeiture, meaning prosecutors assert an interest in its disposition while the criminal case proceeds, although ownership, tracing, valuation, and permanent recovery remain unresolved.
The forfeiture allegation identifies the government’s requested remedy but does not establish McMillan’s guilt, validate the alleged source of funds, defeat third-party interests, or guarantee that the United States will ultimately obtain the residence.
Count Six Concerns Kentucky Real Estate
Count Six alleges a $1.3 million transaction dated May 21, 2024, from another account in McMillan’s name and connected to property at 1058 Majestic Oaks Way in Simpsonville, Kentucky, the largest listed real-estate payment.
That transfer allegedly occurred shortly after a Texas podiatrist received one Medicare payment and one denial for Protectus products, an episode prosecutors use elsewhere to illustrate reimbursement-dependent invoicing, although the indictment does not directly connect those specific claims with Kentucky.
Investigators must instead trace the money through the originating account, distinguishing transaction-specific evidence from broader examples used to explain how the alleged provider-profit arrangement operated across different practices, payment periods, and every intervening transfer under examination.
The Kentucky property appears again in the forfeiture section, allowing prosecutors to seek real estate allegedly acquired with proceeds while also pursuing a money judgment or substitute assets if directly traceable property becomes unavailable.
McMillan and any qualifying third party can contest ownership interests, financing sources, equity calculations, transfers, improvements, liens, and tracing assumptions, ensuring that the asset dispute may involve issues different from the ultimate criminal verdict.
Count Seven Identifies Del Mar Property
Count Seven concerns an approximately $1,041,625 transfer dated October 30, 2024, from a second Protectus LLC account and associated with property at 117 Sixth Street in Del Mar, California, another address included in the forfeiture allegations.
By this point, prosecutors allege the Protectus arrangement had operated for more than five years, enabling investigators to review a large financial record containing provider checks, program reimbursements, invoices, sales commissions, refunds, product expenditures, and owner distributions.
The Del Mar transaction will likely require evidence showing precisely how funds entered the identified Protectus account and whether intervening transfers, legitimate revenue, financing, or commingling weaken the claimed connection with specified unlawful activity.
If the government uses a lowest-intermediate-balance, proportional, or transaction-specific tracing method, the defense can challenge whether that methodology fits the account history, governing precedent, and evidentiary record developed during discovery and expert analysis.
Expensive coastal property may reinforce the prosecution’s lifestyle narrative, but real-estate value, location, and visual appeal cannot establish criminal derivation without the banking and business evidence presented to the jury.
Counts Eight and Nine Cover an Escalade and Private Jet
Count Eight identifies a $50,000 transaction dated March 13, 2025, from the same Protectus account associated with the Del Mar payment and connected to a 2023 Cadillac Escalade described by its vehicle identification number.
As with the Lamborghini count, the listed amount may represent only part of the acquisition, making sales records, financing documents, title history, insurance files, and account statements important for identifying what the payment accomplished.
Count Nine alleges an approximately $2,557,325 transaction dated September 16, 2025, from an Elite Elevated Enterprises LLC account and connected to a 1997 Cessna Citation VII, the largest individual payment in the transaction table.
Elite Elevated Enterprises is not among the six Nevada entities collectively defined as Protectus, so prosecutors must explain how funds in that separate company’s account allegedly derived from the healthcare conspiracies attributed to McMillan and Protectus.
That entity distinction may create a particularly important tracing dispute involving ownership, capitalization, intercompany transfers, loans, asset use, accounting treatment, and whether the aircraft payment contained proceeds from challenged claims or independent funds.
The indictment nevertheless characterizes McMillan as acting individually and through described entities, signaling that the government intends to connect multiple accounts and corporate names within one financial narrative rather than examine each company in isolation.
The Seven Counts Total About $6.28 Million
Adding the approximate amounts listed in Counts Three through Nine produces $6,279,582, but that calculation describes only the seven charged transactions and should never be presented as the total allegedly obtained, laundered, seized, or forfeitable.
The government’s approximately $268 million figure represents program payments on challenged skin-substitute claims, while the alleged $174 million Protectus share and $94 million provider share describe how that broader reimbursement stream was divided.
Likewise, the approximately $27 million allegedly paid to sales representatives came from Protectus receipts rather than representing an additional government loss automatically added to $268 million, preventing misleading multiplication of overlapping financial categories.
Authorities separately reported seizing assets valued near $35 million in McMillan’s case, a figure substantially exceeding the seven listed transfers and suggesting that restraint activity reached property beyond the transaction amounts specifically charged.
Seized value remains an allegation-driven enforcement measure rather than an adjudicated recovery, and market estimates, outstanding debt, third-party interests, preservation expenses, depreciation, and eventual court rulings can materially change what the government ultimately retains.
Originating Accounts Create a Financial Roadmap
The transaction table identifies two accounts held in McMillan’s name, three Protectus LLC accounts appearing across four counts, and one Elite Elevated Enterprises account, giving investigators a defined roadmap for subpoenas, warrants, tracing, and expert reconstruction.
Bank records can reveal incoming provider checks, transfers from related entities, wire origins, account balances, payment memos, authorized signers, closing wires, dealer payments, aircraft escrow activity, beneficial ownership relationships, and communications surrounding each charged date.
Corporate books can then connect those entries with invoice numbers, reimbursement reports, product purchases, commission schedules, owner distributions, loans, tax filings, and refunds, allowing prosecutors to argue that financial records corroborate the alleged operational scheme.
Defense accountants may reconstruct the same records differently, identifying lawful deposits, timing gaps, restricted funds, financing proceeds, retained earnings, documented intercompany obligations, or accounting practices inconsistent with the government’s proposed route across the relevant period.
The outcome may depend upon granular evidence rather than headline totals, because a jury evaluating seven financial counts must decide what McMillan knew when each transaction occurred and what property actually funded it.
Commingled Money Can Complicate Both Sides
Healthcare businesses commonly deposit receipts from numerous providers, products, payers, and service lines into operating accounts that also fund inventory, payroll, commissions, taxes, rent, insurance, debt, refunds, owner compensation, and recurring capital expenditures.
When allegedly illegal and legitimate revenue coexist, prosecutors may rely on accepted tracing principles and circumstantial evidence, while defendants may argue that the selected transaction drew on clean funds or that the government cannot reliably identify a qualifying source.
The indictment’s claim that government programs would not pay kickback-induced services supports the prosecution’s assertion that the reimbursement stream was criminally generated, yet McMillan can dispute whether every underlying claim was false, tainted, or ineligible.
Products may have been delivered, and patients may have received clinically useful treatment, but those circumstances would not necessarily defeat a proven kickback or false-pricing theory, just as high reimbursement alone cannot establish criminal deception.
Claim sampling, medical necessity, acquisition-cost reporting, provider independence, discount protections, and safe-harbor analysis may consequently influence both predicate liability and the amount of money prosecutors can characterize as proceeds during tracing disputes covering the alleged period.
Seizure and Forfeiture Are Different Stages
The indictment seeks forfeiture of property constituting, derived from, involved in, or traceable to the charged offenses, depending upon the particular count and statutory theory, while also requesting a money judgment based upon alleged gross proceeds.
Its property list includes the four residences associated with the transaction counts, plus a condominium at 2000 Fashion Show Drive in Las Vegas, showing that the forfeiture request extends beyond the assets itemized in Counts Three through Nine.
The filing also invokes substitute-asset procedures if directly forfeitable property cannot be located, was transferred to another person, moved beyond court jurisdiction, substantially diminished, or commingled so extensively that division becomes difficult before prosecutors can recover equivalent property.
Pretrial seizure or restraint aims to preserve property for possible forfeiture, but permanent forfeiture generally requires the government to satisfy applicable burdens while allowing defendants and qualifying third parties to assert recognized ownership or tracing challenges.
Accordingly, reports that authorities seized approximately $35 million should not be rewritten as proof that $35 million was laundered, because seizure value, charged transaction value, alleged proceeds, program payments, and final forfeiture are legally distinct concepts.
The Predicate Conspiracies Remain Essential
The seven monetary-transaction counts depend upon property allegedly derived from Count One’s healthcare-fraud conspiracy and Count Two’s conspiracy to defraud the United States while paying kickbacks connected to a federal healthcare program identified by prosecutors.
If prosecutors cannot establish the required predicate criminal activity or cannot connect a particular transaction with its proceeds, the financial count associated with that transfer may fail regardless of how expensive or personally appealing the property appears.
Count One alleges materially false claim information and kickback-induced billing, including acquisition prices that allegedly failed to reflect discounts, rebates, refunds, or other adjustments when providers sought reimbursement for skin-substitute products within government-program submissions.
Count Two focuses upon alleged remuneration to providers and sales representatives, concealment of claims and kickbacks, interference with Medicare administration, and diversion of proceeds for personal benefit through conduct prosecutors say continued nearly seven years.
At trial, McMillan can challenge the agreement, intent, materiality, billing responsibility, claim interpretation, provider autonomy, representative compensation, discount treatment, witness credibility, and whether the government has compressed varied commercial relationships into one unlawful narrative.
Luxury Evidence Can Persuade or Prejudice
Real estate, exotic vehicles, and a private jet give prosecutors concrete images that can make an otherwise technical reimbursement case understandable, helping jurors visualize how authorities believe public healthcare money moved into private wealth.
That storytelling power also raises prejudice concerns, because jurors may dislike extravagant spending even when wealth was lawfully earned, encouraging defense motions to limit lifestyle evidence that lacks a sufficiently direct connection to the charged conduct.
Courts may evaluate whether individual purchases prove motive, intent, knowledge, proceeds, or financial control, while balancing their probative value against the danger that luxury branding could invite punishment for affluence rather than proven crime.
The strongest government presentation would therefore pair each recognizable asset with bank records, corporate ledgers, claim proceeds, communications, and ownership evidence, while the defense will emphasize any gap between emotional imagery and element-specific proof.
Neither a Lamborghini nor a private aircraft establishes healthcare fraud by appearance, and neither becomes criminal property merely because its owner operated a business receiving substantial payments from federally funded medical programs without additional financial evidence.
Medicare, TRICARE, and CHAMPVA Financed the Alleged Claims
The challenged payments allegedly came from Medicare, which serves older and disabled beneficiaries, TRICARE, which covers eligible military communities, and CHAMPVA, which supports qualifying spouses, children, and survivors connected with veterans across the country.
Skin substitutes can provide legitimate value for carefully selected chronic wounds, making accurate documentation, independent clinical judgment, transparent acquisition pricing, and compliant commercial relationships essential to separating appropriate treatment from reimbursement-driven product selection.
Prosecutors say Protectus removed provider downside by offering products without upfront cost, declining charges after denied claims, helping with billing, and allowing practices to retain thousands of dollars whenever government reimbursement succeeded at participating medical practices.
Medical practices should recognize that distributor assistance does not transfer responsibility for claim accuracy, medical necessity, acquisition-cost disclosures, or kickback compliance away from the enrolled provider whose identifier and certification support government payment.
Distributors should also understand that contractual labels cannot turn remuneration into a lawful discount when the underlying economic arrangement allegedly rewards federally reimbursed orders, although falling outside a safe harbor does not automatically establish criminal intent.
A Major Case in the 2026 Federal Takedown
McMillan’s prosecution emerged during the Justice Department’s 2026 National Health Care Fraud Takedown, which announced charges against 455 defendants across 56 federal districts in alleged schemes collectively involving more than $6.5 billion in false claims.
The Northern District of Texas announced seven cases involving thirteen defendants and more than $365 million in alleged fraudulent billing, with McMillan’s approximately $268 million wound-care matter representing the district’s largest disclosed payment total.
Independent NBC 5 Dallas-Fort Worth reporting on the North Texas enforcement action highlighted the houses, luxury vehicles, and private jet tied to the allegations, while describing other cases involving military families, older patients, laboratories, hospice, and medical equipment.
Federal officials credited investigators from the Federal Bureau of Investigation, the Department of Health and Human Services inspector general, the Defense Criminal Investigative Service, and the Department of Veterans Affairs inspector general with developing the McMillan case.
That multiagency structure reflects the payer mix and lets investigators combine claims analytics, beneficiary information, provider interviews, corporate evidence, banking records, program rules, and asset-tracing expertise into a coordinated federal prosecution developed over several years.
Analytics Can Connect Claims with Purchases
Investigators can align reimbursement dates with provider checks, Protectus deposits, intercompany transfers, owner distributions, and purchase wires, producing chronological maps that show whether alleged proceeds moved toward particular assets soon after arriving across several related accounts.
They can also compare providers’ product usage before and after recruitment, repeated invoice percentages, denied-claim treatment, representative commissions, Box 19 pricing, claim volumes, beneficiary histories, and the timing of large personal acquisitions across time and location.
Patterns can guide subpoenas and flag transactions that need explanation, but statistical abnormality remains an investigative signal, not proof, because rapid lawful growth, new service lines, specialized patients, or legitimate financing can produce unusual results.
The evidentiary question is whether the data align with contracts, spreadsheets, emails, invoices, bank records, witness testimony, and claim instructions demonstrating knowing misconduct, or whether the full context provides credible lawful explanations for the same movement.
Asset tracing becomes particularly persuasive when independent records converge upon one route, while inconsistent dates, unexplained assumptions, missing legitimate deposits, or unreliable witness accounts can weaken the government’s interpretation of complicated financial history.
Compliance Lessons from the Alleged Money Trail
Healthcare distributors should maintain product-level pricing records, written discount methodologies, rebate disclosures, denial policies, commission agreements, and transaction logs that allow an auditor to reconstruct the economics of every federally reimbursed sale within each provider relationship.
Owner distributions and large asset purchases should undergo documented source-of-funds review whenever a company depends heavily upon government healthcare reimbursements, particularly when pending refunds, disputed invoices, contingent pricing, or compliance concerns create uncertainty about revenue.
Affiliated companies should document intercompany loans, management fees, transfers, shared employees, intellectual property, and asset ownership, preventing legitimate corporate complexity from appearing designed to obscure where government-derived money entered or moved across every related business.
Boards and compliance officers should trace sample transactions from product acquisition through shipment, clinical application, claim submission, program payment, provider invoice, rebate adjustment, company deposit, representative commission, owner distribution, and any later property purchase.
Those controls cannot guarantee that investigators will accept every commercial judgment, but contemporaneous documentation provides far stronger evidence of good faith than explanations reconstructed only after subpoenas, seizures, or criminal charges arrive under later scrutiny.
Responding to Financial-Crime Allegations Lawfully
A prosecution combining healthcare fraud, kickbacks, money tracing, luxury assets, and forfeiture can produce immediate reputational consequences for executives, companies, employees, providers, lenders, manufacturers, landlords, and family members before any factfinder reaches a verdict.
Amicus International Consulting publishes information concerning lawful due diligence, cross-border planning, privacy, identity integrity, and reputational exposure while distinguishing legitimate risk management from concealment intended to obstruct investigators, courts, creditors, regulators, or reporting duties.
Its crisis public-relations guidance emphasizes organized assessment and disciplined communication, principles that remain lawful only when statements are accurate, evidence is preserved, procedural status is clear, and nobody pressures witnesses or conceals relevant property.
Companies facing federal scrutiny should suspend routine deletion, preserve messages and financial records, identify authorized spokespeople, coordinate factual statements with qualified counsel, and avoid transferring assets in ways that could create additional obstruction or forfeiture allegations.
Reputation management cannot erase an indictment or replace a legal defense, but accurate timelines, documented corrections, careful terminology, and transparent updates can reduce misinformation while preserving the critical distinction between allegations, evidence, judicial rulings, and final adjudication.
What Prosecutors Must Establish
For each financial count, prosecutors must prove that McMillan knowingly conducted or attempted a qualifying transaction exceeding $10,000 with property derived from specified unlawful activity, while satisfying jurisdictional requirements and connecting the money with the charged predicates.
They need not prove that McMillan knew the precise statutory designation of the alleged underlying crime, but they must establish the knowledge required by law rather than relying solely upon his ownership, control, wealth, or spending.
The government must also demonstrate that the predicate conspiracies produced unlawful proceeds, an issue potentially affected by claim validity, kickback purpose, acquisition-cost disclosures, provider conduct, product delivery, materiality, and the scope of any proven agreement.
McMillan’s defense may challenge warrants, subpoenas, account tracing, expert methodology, commingling assumptions, entity boundaries, witness incentives, venue, forfeiture notices, transaction descriptions, and whether selected claim examples fairly represent the broader business before trial or sentencing.
Cooperating providers, representatives, employees, accountants, or billing specialists may become important witnesses, but jurors must evaluate their documentary support, financial exposure, immunity arrangements, personal interests, and consistency before accepting their explanations of disputed payments.
What Happens Next in the Michael McMillan Case
The case will proceed through discovery, pretrial motions, expert review, asset litigation, and possible negotiations, with years of claims data, provider records, corporate books, bank statements, closing files, communications, and product documentation potentially requiring analysis.
Possible disputes include whether challenged rebates were kickbacks, whether reported acquisition prices were materially false, whether Protectus receipts qualify as proceeds, and whether each listed transaction can be traced through accounts containing mixed revenue.
The government may seek permanent forfeiture following qualifying convictions, while McMillan and third parties can contest tracing, ownership, valuation, liens, substitute assets, and the relationship between charged transfers and properties identified elsewhere in the forfeiture notice.
No responsible account can predict the outcome from an indictment containing large numbers and recognizable luxury assets, because convictions require evidence tested through constitutional procedures in federal court rather than repetition of the government’s accusations.
The central financial allegation remains direct: prosecutors say McMillan moved proceeds from illegal Medicare, TRICARE, and CHAMPVA wound-care claims into real estate, luxury vehicles, and a private aircraft through seven transactions exceeding the federal threshold.
Most importantly, Michael McMillan remains presumed innocent; every healthcare-fraud, kickback, monetary-transaction, and forfeiture allegation remains unresolved, and criminal responsibility can arise only through a valid guilty plea or proof beyond a reasonable doubt.